Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
The US minimally invasive spine technology market will experience moderate growth through 2027, primarily as a result of growing demand for innovative technologies, such as 3-D–printed implants and robotic-assisted surgeries. Furthermore, the shift toward performing spine surgeries at outpatient settings will also drive the use of premium-priced minimally invasive devices. Various company acquisitions, new device approvals, extensive marketing and sales efforts by manufacturers, and favorable reimbursement policies will support modest procedure volume growth.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for minimally invasive spine technologies in the US across a 10-year period.
Some segments of the minimally invasive spine procedures will show modest growth through 2027.
What procedures are growing the fastest, and how quickly are they growing?
What factors will most impact market growth ?
How has the shift from hospital settings to ASCs and outpatient settings affected the minimally invasive spine market?
Innovative technologies are helping companies to gain a competitive advantage.
How have technologies like guidance systems and robotics helped companies to broaden their portfolios?
What types of implants are being manufactured using 3-D printing?
What are the potential benefits of 3-D printing and how will it affect the adoption of certain implants?
Strategic acquisitions, partnerships, and distribution deals help manufacturers expand their product portfolios and customer bases.
Which competitors have recently engaged in M&A?
Which segments are most affected by such activity?
What are the benefits for companies partnering with or acquiring other competitors in this market?
Already a Client? Log in to access this report.
Diksha Garg is a research associate within the Orthopedics and Dental Medtech Insights team at Decision Resources Group, specializing in European dental implant markets. Diksha holds a Bachelor's degree in Pharmaceutical Sciences from the Delhi Institute of Pharmaceutical Sciences and Research and a Master's degree in Medicinal Chemistry from the National Institute of Pharmaceutical Education and Research, Mohali.
Monica Lin is an analyst within the Orthopedics and Dental Medtech Insights team at Decision Resources Group. Monica holds an Honors Bachelor's degree in Life Physics and Economics from the University of Waterloo.